Boston Scientific (BSX) Research

Founded in 1979, BSX is a leading global medical device company headquartered in Marlborough, Massachusetts. The company operates through two main business segments—MedSurg and Cardiovascular—and develops, manufactures, and sells a wide range of innovative medical devices required for minimally invasive procedures and precision therapies. Its flagship products include the left atrial appendage closure device WATCHMAN FLX, digital catheters, endoscopes, and electrophysiology devices, all of which generate stable revenue in major markets worldwide, supported by steady demand and strong trust from physicians and patients.